Konigstein, Germany

Dieter Mania


Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 127(Granted Patents)


Location History:

  • Kelkheim, Taunus, DE (1978)
  • Kelkheim Taunus, DE (1988)
  • Kelkheim, DE (1979 - 1994)
  • Konigstein/Taunus, DE (1994)
  • Konigstein am Taunus, DE (1994)
  • Konigstein, DE (1992 - 2000)
  • Königstein, DE (2002)

Company Filing History:


Years Active: 1978-2002

Loading Chart...
31 patents (USPTO):Explore Patents

Title: Dieter Mania: Innovator in Pharmaceutical Chemistry

Introduction

Dieter Mania is a notable inventor based in Königstein, Germany, known for his significant contributions to pharmaceutical chemistry. With an impressive portfolio of 31 patents, he has made remarkable strides in the development of compounds aimed at improving cardiac health.

Latest Patents

His latest patents include the innovative "Substituted benzenesulfonylureas and thioureas - process for their preparation and their use as pharmaceuticals." These compounds play a crucial role in treating disturbances in cardiac rhythm and preventing sudden cardiac death caused by arrhythmia. Specifically, they are particularly beneficial for patients experiencing arrhythmias due to narrowing of a coronary vessel, such as in cases of angina pectoris or acute cardiac infarction.

Career Highlights

Dieter Mania's exemplary career has unfolded at Hoechst Aktiengesellschaft, a prominent firm in the pharmaceutical industry. His research has paved the way for advancements in antiarrhythmic medications that are critical for patient care in cardiology. His consistent dedication to innovation has earned him respect and recognition in the field.

Collaborations

Throughout his career, Dieter Mania has collaborated with several esteemed professionals, including Heinrich Christian Englert and Joachim Kaiser. These partnerships have facilitated a rich exchange of ideas and have contributed to the further development of his groundbreaking work in pharmaceutical science.

Conclusion

Dieter Mania stands out as a pivotal figure in the realm of pharmaceuticals, particularly in the development of compounds that address serious cardiac issues. His extensive patent portfolio and collaborative efforts with other professionals underscore his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…